Halozyme
HALO
410 hedge funds and large institutions have $4.66B invested in Halozyme in 2023 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 145 increasing their positions, 147 reducing their positions, and 36 closing their positions.
291% more call options, than puts
Call options by funds: $18.9M | Put options by funds: $4.84M
75% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 36
5% more funds holding
Funds holding: 389 → 410 (+21)
1.98% more ownership
Funds ownership: 93.38% → 95.36% (+2%)
1% less capital invested
Capital invested by funds: $4.71B → $4.66B (-$45.7M)
1% less repeat investments, than reductions
Existing positions increased: 145 | Existing positions reduced: 147
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$62.6M |
| 2 |
Morgan Stanley
New York
|
+$57.5M |
| 3 |
EIP
Epoch Investment Partners
New York
|
+$31.3M |
| 4 |
BlackRock
New York
|
+$19.3M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
+$17.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$78.3M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$38.6M |
| 3 |
SCM
Snyder Capital Management
San Francisco,
California
|
-$23.1M |
| 4 |
Millennium Management
New York
|
-$22.2M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$15.3M |
HALO Hedge Fund Activity: Q4 2023 in Review
410 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q4 2023, worth a combined $4.66B — down 0.97% from $4.71B a quarter earlier.
Buyers outnumbered sellers: 63 funds opened new HALO positions and 36 closed out — a net gain of 27 holders — while 145 added to existing stakes and 147 trimmed.
The largest buyer was TD Asset Management, adding an estimated $62.6M. The largest seller was Marshall Wace, cutting an estimated $78.3M.
- 410 institutional investors held Halozyme (HALO) as of Q4 2023, up from 389 in Q3 2023.
- Funds reported $4.66B of Halozyme stock for Q4 2023, down 0.97% quarter-over-quarter.
- 63 funds opened new Halozyme positions in Q4 2023 and 36 closed out, a net change of +27 holders.
- The largest Halozyme buyer in Q4 2023 was TD Asset Management, an estimated $62.6M added.
- The largest Halozyme seller in Q4 2023 was Marshall Wace, an estimated $78.3M sold.
Based on aggregated 13F filings for Q4 2023.